Article

Rapid Recovery from COVID-19 Respiratory Failure with Comorbidity in 21 Patients Treated with Vasoactive Intestinal Peptide

2020-09-18

Abstract excerpt

Background: Vasoactive Intestinal Peptide (VIP) is known to bind to and protect Alveolar Type II cells by blocking replication of the SARS-CoV-2 virus, inhibiting cytokine synthesis, preventing cytopathy, and upregulating surfactant production. RLF-100™ (aviptadil), a synthetic form of VIP has been granted Fast Track Designation for treating Critical COVID-19 with Respiratory Failure and is currently in phase 2/3...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 20e104a1-2e82-5e3a-8a4f-6e6f85662459
DOI: 10.2139/ssrn.3679909

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Rapid Recovery from COVID-19 Respiratory Failure with Comorbidity in 21 Patients Treated with Vasoactive Intestinal PeptideDOI 10.2139/ssrn.3679909Read

Rapid Recovery in Six Patients with COVID-19 Respiratory Failure after Treatment with Vasoactive Intestinal PeptideSemantic proximity Read

Inhaled Aviptadil for the treatment of COVID-19 in patients at high risk for ARDS: Study protocol for a randomized, placebo controlled multicentre trial.Semantic proximity Read

Respiratory management of adult patients with acute respiratory distress syndrome due to COVID-19.Semantic proximity Read

Supportive Management and Interventions for Respiratory Failure Due to SARS-CoV-2.Semantic proximity Read

A phase 2 study of the inhaled pan-JAK inhibitor TD-0903 in severe COVID-19: Part 1Semantic proximity Read

Inhaled nitric oxide use in COVID19-induced hypoxemic respiratory failureSemantic proximity Read

Clinical Outcomes of Implementing Two Management Protocols for Acute Respiratory Distress Patients with COVID-19: A Randomized Controlled TrialSemantic proximity Read

Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trialSemantic proximity Read

207 Days of Veno-Venous Extracorporeal Membrane Oxygenation Support for Severe COVID-19 Prior to Successful Lung Transplant: A Case ReportSemantic proximity Read

VIP modulates human macrophages phenotype via FPRL1 via activation of RhoA-GTPase and PLC pathways.Semantic proximity Read

Therapeutic efficacy of stable analogues of vasoactive intestinal peptide against pathogens.Semantic proximity Read

<i>In-silico</i> modeling of COVID-19 ARDS: pathophysiological insights and potential management implicationsSemantic proximity Read